Lincoln Pharmaceuticals Ltd
Company Profile
Business description
Lincoln Pharmaceuticals Ltd is an India-based company engaged in the business of manufacturing and trading of pharmaceutical products. It offers products in the fields of cardiac, diabetic, anti-malarial, anti-biotic, anti-fungal, cephalosporin, analgesics, anesthetics, anti-pyretic, GIT products, vitamin-minerals, and iron preparations. Some of the key brands through which the company markets its products are; Rhino, Binafin, Kezolin, Hepalin, Progut, and Vomistat among others. Geographically, the company carries out sales in India and outside India; generating key revenue from outside India.
Contact
Science City Road
Lincoln House
Behind Satyam Complex
Sola
AhmedabadGJ380060
INDT: +91 7941078000
Sector
Healthcare
Stock type
Defensive
Industry
Drug Manufacturers - Specialty & Generic
Fiscal Year End
31 March 2027
Employees
1,352
Stocks News & Analysis
stocks
Two cheap wide moat ASX shares
stocks
Anthropic: Are the shares undervalued given the IPO pricing range?
stocks
Valuation looks stretched for ASX healthcare share
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
|---|---|---|---|
| All Ordinaries | 9,274.20 | 17.10 | -0.18% |
| CAC 40 | 8,390.03 | 57.16 | 0.69% |
| DAX 40 | 26,865.49 | 202.72 | 0.76% |
| Dow JONES (US) | 52,486.49 | 254.60 | 0.49% |
| FTSE 100 | 10,872.19 | 36.72 | 0.34% |
| HKSE | 24,008.55 | 307.37 | -1.26% |
| NASDAQ | 25,466.19 | 400.32 | 1.60% |
| Nikkei 225 | 60,819.36 | 429.23 | -0.70% |
| NZX 50 Index | 14,259.23 | 79.37 | 0.56% |
| S&P 500 | 7,619.38 | 98.45 | 1.31% |
| S&P/ASX 200 | 9,146.80 | 6.40 | -0.07% |
| SSE Composite Index | 3,655.83 | 24.81 | -0.67% |